Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy.

Journal of clinical pharmacy and therapeutics - 1 Aug 2007

Doki K, Homma M, Kuga K, Kawano S, Aonuma K, Yamaguchi I, Kohda Y

Abstract excerpt

A 72-year-old male patient with dilated cardiomyopathy was treated with oral flecainide (100 mg/day) for persistent atrial fibrillation (AF) that could not be converted to sinus rhythm by electrical cardioversion. Initiation of flecainide treatment provided sinus rhythm without prolongation of QR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Arrhythmia Agents
Share to Atrial Fibrillation
Share to Cardiac Pacing, Artificial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiomyopathy, Dilated

Share to Electric Countershock

Share to Electrocardiography

Share to Flecainide

Share to Heart Rate

Source

Identifiers

PMID: 17635343
DOI: 10.1111/j.1365-2710.2007.00837.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17635343-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy.PMID 17635343Read ↗

Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia.Semantic proximity Read ↗

[Use of Pharmacogenetic Information for Therapeutic Drug Monitoring of an Antiarrhythmic Drug].Semantic proximity Read ↗

Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.Semantic proximity Read ↗

Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia.Semantic proximity Read ↗

Insights on the mechanism of flecainide in catecholaminergic polymorphic ventricular tachycardia.Semantic proximity Read ↗

Long-term Serial Exercise Stress Testing in Catecholaminergic Polymorphic Ventricular Tachycardia on Beta-Blocker and Flecainide TherapySemantic proximity Read ↗

Relevance of CYP2D6 in the Efficacy and Toxicity of Flecainide in Patients With Atrial Fibrillation: A Cohort Study.Semantic proximity Read ↗

Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.